Table 4.
Association between biomarkers and severe leptospirosis by type of organ failure (represented by p-value).
| Parameters | Severe coagulopathy | Severe renal failure | Severe liver failure | Severe cardiovascular system failure | Pulmonary hemorrhage | Severe respiratory failurea |
|---|---|---|---|---|---|---|
| Leptospiremia at day 1 | 0.003* | 0.215 | 0.129 | 0.009* | 0.001* | 0.013* |
| Leptospiremia at day 7 | 0.421 | 0.843 | 0.871 | 0.692 | NA | 0.943 |
| MAT titer at day 1 | 0.127 | 0.907 | 0.722 | 0.286 | 0.286 | 0.477 |
| MAT titer at day 7 | 0.032* | 0.803 | 0.327 | 0.087 | 0.034* | 0.231 |
| MAT titer at any day | 0.121 | 0.716 | 0.313 | 0.084 | 0.033* | 0.227 |
| Plasma NGAL at day 1 | 0.002* | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
| IL-6 at day 1 | 0.003* | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
pNGAL plasma neutrophil gelatinase-associated lipocalin, IL-6 interleukin 6, MAT microscopic agglutination test, NA not available.
*p-value < 0.05.
aSevere respiratory failure was defined as requiring mechanical ventilation. The data were expressed as a p-value from the Mann–Whitney U test.